Autocrine TNF-α-mediated NF-κB activation is a determinant for evasion of CD40-induced cytotoxicity in cancer cells

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 467-472

  Li, Daoxia ^a   Zhong, Yingjia ^a   Zhou, Yuqiong ^a   Sun, Hong ^b   Zheng, Xuelian ^b   Zhao, Chen ^a   Yan, Youyi ^a   Lin, Yong ^b   Liao, Linchuan ^a   Wang, Xia ^b  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Autocrine; Cancer; CD40 rsCD40L; Cell death; NF B; TNF

Indexed keywords

CD40 LIGAND; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUTEOLIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; GROWTH REGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

AUTOCRINE; CANCER; CD40/RSCD40L; CELL DEATH; NF-ΚB; TNF-Α;

ANTIBODIES, NEUTRALIZING; ANTIGENS, CD40; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOCRINE COMMUNICATION; BENZOQUINONES; CD40 LIGAND; CELL LINE, TUMOR; HUMANS; I-KAPPA B KINASE; LACTAMS, MACROCYCLIC; LUTEOLIN; NF-KAPPA B; TUMOR ESCAPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879881286     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.128     Document Type: Article

References (21)

1. Ahonen C., Manning E., Erickson L.D., O'Connor B., Lind E.F., Pullen S.S., Kehry M.R., Noelle R.J. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat. Immunol. 2002, 3:451-456.
2. Jabara H., Laouini D., Tsitsikov E., Mizoguchi E., Bhan A., Castigli E., Dedeoglu F., Pivniouk V., Brodeur S., Geha R. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 2002, 17:265-276.
3. Lu L.F., Ahonen C.L., Lind E.F., Raman V.S., Cook W.J., Lin L.L., Noelle R.J. The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation. Blood 2007, 110:193-200.
4. Vallabhapurapu S., Matsuzawa A., Zhang W., Tseng P.H., Keats J.J., Wang H., Vignali D.A., Bergsagel P.L., Karin M. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol. 2008, 9:1364-1370.
5. Grammer A.C., Swantek J.L., McFarland R.D., Miura Y., Geppert T., Lipsky P.E. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J. Immunol. 1998, 161:1183-1193.
6. Davies C.C., Mak T.W., Young L.S., Eliopoulos A.G. TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells. Mol. Cell. Biol. 2005, 25:9806-9819.
7. Tong A.W., Stone M.J. Prospects for CD40-directed experimental therapy of human cancer. Cancer Gene Ther. 2003, 10:1-13.
8. Bereznaya N.M., Chekhun V.F. Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy. Exp. Oncol. 2007, 29:2-12.
9. Voorzanger-Rousselot N., Alberti L., Blay J.Y. CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways. BMC Cancer 2006, 6:75.
10. Zheng B., Fiumara P., Li Y.V., Georgakis G., Snell V., Younes M., Vauthey J.N., Carbone A., Younes A. MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood 2003, 102:1019-1027.
11. Eliopoulos A.G., Davies C., Knox P.G., Gallagher N.J., Afford S.C., Adams D.H., Young L.S. CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol. Cell. Biol. 2000, 20:5503-5515.
12. Georgopoulos N.T., Merrick A., Scott N., Selby P.J., Melcher A., Trejdosiewicz L.K. CD40-mediated death and cytokine secretion in colorectal cancer: a potential target for inflammatory tumour cell killing. Int. J. Cancer 2007, 121:1373-1381.
13. Davies C.C., Mason J., Wakelam M.J., Young L.S., Eliopoulos A.G. Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells. J. Biol. Chem. 2004, 279:1010-1019.
14. Coope H.J., Atkinson P.G., Huhse B., Belich M., Janzen J., Holman M.J., Klaus G.G., Johnston L.H., Ley S.C. CD40 regulates the processing of NF-kappaB2 p100 to p52. Embo J. 2002, 21:5375-5385.
15. Berberich I., Shu G.L., Clark E.A. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 1994, 153:4357-4366.
16. Travert M., Ame-Thomas P., Pangault C., Morizot A., Micheau O., Semana G., Lamy T., Fest T., Tarte K., Guillaudeux T. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL. J. Immunol. 2008, 181:1001-1011.
17. Wang X., Ju W., Renouard J., Aden J., Belinsky S.A., Lin Y. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res. 2006, 66:1089-1095.
18. Wang Q., Zheng X.L., Yang L., Shi F., Gao L.B., Zhong Y.J., Sun H., He F., Lin Y., Wang X. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J. Exp. Clin. Cancer Res. 2010, 29:159-166.
19. Sun H., Zhong Y.J., Zheng X.L., Wang Q., Yang L., Shi F., Yan J.Q., He F., Liao L.C., Lin Y., Zhang L., Wang X. Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells. Cancer Sci. 2012, 103:197-202.
20. Georgopoulos N.T., Steele L.P., Thomson M.J., Selby P.J., Southgate J., Trejdosiewicz L.K. A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation. Cell Death Differ. 2006, 13:1789-1801.
21. Davies C.C., Bem D., Young L.S., Eliopoulos A.G. NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells. Cell. Signal. 2005, 17:729-738.